Funds innovative basic and clinical research on pancreatic diseases, especially pancreatic cancer, to advance early detection, diagnosis, treatment, and prevention.
Funder: University of California San Francisco
Due Dates (Anticipated): March 2027 (full application submission deadline, projected)
Funding Amounts: Up to $50,000 per one-year pilot project (direct costs only; non-renewable)
Summary: Supports innovative research on diseases of the pancreas, especially pancreatic cancer, with emphasis on early detection, diagnosis, treatment, and prevention.
This program funds pilot research projects that advance understanding, diagnosis, treatment, or prevention of diseases of the pancreas, with a particular focus on pancreatic cancer and pancreatic ductal adenocarcinoma. Both clinical and basic science proposals are considered, provided they are directly relevant to pancreatic diseases. The goal is to foster innovative research that can lead to significant advancements in the field and position investigators for future larger-scale funding, such as NIH grants. Projects unrelated to pancreatic cancer (e.g., diabetes not linked to pancreatic cancer) are not supported.